A comparison of COVID-19 inpatients by HIV status

• DOI: 10.1177/09564624211023015
• Publication Date: 2021-06-22T15:41:44Z
• Authors: Sarah Flannery; Rebecca Schwartz; Rehana Rasul; David A Hirschwerk; Frances Wallach; Bruce Hirsch; Joseph McGowan
• Keywords: Pandemic

COVID-19 in-hospital morbidity and mortality in people living with HIV (PLWH) were compared to HIV-negative patients within a New York City metropolitan health system, the hardest hit region United States early pandemic. A total of 10,202 inpatients diagnosed COVID-19, which 99 PLWH. PLWH younger (58.3 years (SD = 12.42) versus 64.32 16.77), p < 0.001) had higher prevalence men (73.7% 57.9%, 0.002) Blacks (43.4% 21.7%, than population. malignancies (18% 7%, 0.001), chronic liver disease (12% 3%, end-stage renal (11% 4%, 0.007). Use ventilator, admission ICU, not different. Of PLWH, 12 virally unsuppressed 9 CD4% 14. Two 4/9 14 died. Ninety-one on treatment for HIV, 5 8 Among prior values, absolute CD4 count decreased an average 192 cells/mm 3 at time diagnosis ( 0.001). Hospitalized coinfection did have worse outcomes general those CD4%<14 or rates. Those who received IL-6 inhibitors lower given antifungal medications, hydroxychloroquine, antibiotics (including azithromycin), steroids, vasopressors